Vinpocetinpulver er et menneskeskapt kjemikalie som ligner et stoff som finnes i periwinkle-planten Vinca minor. Folk bruker det som medisin. Folk bruker vinpocetine for å forbedre hukommelse og tenkeferdigheter, øke energi, for vekttap og mange andre forhold, men det er ingen gode vitenskapelige bevis som støtter disse bruksområdene.
Pakke: 1 kg / pose, 25 kg / trommel
03 Vinpocetine powder 42971-09-5 video
No video for now
04 Vinpocetine powder 42971-09-5 Base informasjon
|Ord||AY-27255, Cavinton, Eburnamenine-14-carboxylic acid, Ethyl Apovincaminate, Ethylapovincaminoate, Ethyl Ester, RGH-4405, TCV-3b, Vinpocetin, Vinpocetina, Vinpocétine.|
|Half Life||2 til 4 timer|
|Lagringsforhold||Oppbevares ved romtemperatur, i en forseglet lufttett beholder, hold luften ute, beskyttet mot varme, lys og fuktighet.|
|Søknad||Vinpocetine is used to enhance memory and increase brain metabolism. It has also been used for ischemia and reperfusion injury, and is considered a neuroprotective agent. However, there are few robust clinical studies to support the use of vinpocetine in stroke, dementia, or other diseases of the CNS.|
|Testing av dokument||Tilgjengelig|
05 Vinpocetine powder 42971-09-5 General Description
Vinpocetine powder is a synthetic compound derived from vincamine, a substance found naturally in the leaves of the lesser periwinkle plant (Vinca minor). Vinpocetine was developed in the late 1960s and is available as a prescription drug in Europe and Japan under the brand names Cavinton, Cavinton Forte, Intelectol, and others.
Vinpocetine is used to enhance memory and increase brain metabolism. It has also been used for ischemia and reperfusion injury, and is considered a neuroprotective agent. However, there are few robust clinical studies to support the use of vinpocetine in stroke, dementia, or other diseases of the CNS.
06 Vinpocetine powder 42971-09-5 History
Vinpocetine was first synthesized in the late 1960s from vincamine and has been sold under commercial names, such as Cavinton and Intelectol, since the late 1970s. Vinpocetine is primarily promoted for use in cerebral disorders of vascular origin, while V. minor has multiple purported, traditional uses including laxative, antilactaogogue, and emmenagogue.
07 Vinpocetine powder 42971-09-5 Mechanism Of ADette skjer
The mechanisms of vinpocetine powder are numerous. It appears to interact with several ion channels (sodium, potassium, and calcium) while tends to result in suppressive effects on neurotransmitter release and neuroprotection when dopamine or glutamate are suppressed (these two, when unnecessarily stimulated by toxins, can cause oxidative damage). It also interacts with alpha adrenergic receptors and the TPSO receptor, and while the exact benefit of these receptor interactions are not clear they are probably relevant since they occur at the same concentrations that the ion channel interactions do.
Vinpocetine er også en PDE1-hemmer, som er en mekanisme som både er kardiobeskyttende og kognitiv forbedrende. Dessverre forekommer denne inhiberingen i en ganske stor dose og gjelder kanskje ikke standard tilleggsdoser av vinpocetin.
I likhet med PDE1 ser det ut til at et antidopaminergt potensial for vinpocetin og direkte inhibering av glutaminerge reseptorer forekommer i svært høye konsentrasjoner in vitro og kanskje ikke er relevant for standardtilskudd.
08 Vinpocetine powder 42971-09-5 Application
- Improve symptoms of Alzheimer’s disease
Vinpocetine initially gained notice because it was said to increase blood flow to the brain, an effect some believed could improve symptoms of Alzheimer’s disease.
Others have ascribed it with thermogenic properties, suggesting that it could “burn fat” or enhance exercise performance.
Results have been seen when evaluating the vinpocetine as a weight loss or sports supplement.
One study published in 2016, conducted at the University of South Florida in 2016, reported that a fat-burning supplement containing vinpocetine increase the resting metabolic rate (RMR) in 10 male athletes but did nothing to decrease their body fat.
09 Vinpocetine powder 42971-09-5 More research
When taken by mouth: Vinpocetine is POSSIBLY SAFE for most people when taken by mouth appropriately, short-term. Vinpocetine can cause some side effects including stomach pain, nausea, sleep disturbances, headache, dizziness, nervousness, and flushing of the face.
10 Vinpocetine powder 42971-09-5 Document Download
11 Vinpocetine powder 42971-09-5 Reference
 Cohen, Pieter A. (October 2015). “Vinpocetine: An Unapproved Drug Sold as a Dietary Supplement”. Mayo Clinic Proceedings. 90 (10): 1455. doi:10.1016/j.mayocp.2015.07.008. PMID 26434971.
 National Toxicology Program (September 2013). “Chemical Information Review Document for Vinpocetine (CAS No. 42971-09-5)” (PDF). U.S. Department of Health and Human Services. Retrieved December 28, 2018.
 Almada, Bianca (July 6, 2015). “False claims for brain supplement draw $152 million penalty from FTC”. Orange County Register. Retrieved January 1, 2019.
 Myers, Steve (July 8, 2015). “Memory Supplement Marketers Settle FTC Case for $150M”. Natural Products Insider. Retrieved 1 January 2019.
- 01. Oversikt
- 02. Kontakt
- 03. Vinpocetine powder 42971-09-5 video
- 04. Vinpocetine powder 42971-09-5 Base informasjon
- 05. Vinpocetine powder 42971-09-5 General Description
- 06. Vinpocetine powder 42971-09-5 History
- 07. Vinpocetine powder 42971-09-5 Mechanism Of ADette skjer
- 08. Vinpocetine powder 42971-09-5 Application
- 09. Vinpocetine powder 42971-09-5 More research
- 10. Vinpocetine powder 42971-09-5 Document Download
- 11. Vinpocetine powder 42971-09-5 Reference